Department of Hepatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.
Euroasian J Hepatogastroenterol. 2016 Jan-Jun;6(1):43-44. doi: 10.5005/jp-journals-10018-1164. Epub 2016 Jul 9.
Viral hepatitis poses huge burden to the health care delivery system as well as to the economy of Bangladesh. Hepatitis E virus is the leading cause of acute hepatitis in this country, however with the improvement of economic status and sanitation this seems to be on the decline. Hepatitis B virus remains the leading cause in all forms of chronic liver diseases in this country. This virus has been extensively studied in Bangladesh, including from epidemiology to pathogenosis. Clinical trials with innovative therapy conducted in Bangladesh have shown promise. Hepatitis C virus follows hepatitis B virus as the second commonest cause of chronic liver diseases here. However patients in Bangladesh have started benefitting from the local generic versions of the newly introduced direct acting anti-virals.
Al-Mahtab M. Past, Present, and Future of Viral Hepatitis in Bangladesh. Euroasian J Hepato-Gastroenterol 2016;6(1):43-44.
病毒性肝炎给孟加拉国的医疗保健系统以及经济带来了巨大负担。戊型肝炎病毒是该国急性肝炎的主要病因，然而随着经济状况和卫生条件的改善，这种情况似乎正在下降。乙型肝炎病毒仍然是该国所有形式慢性肝病的主要病因。这种病毒在孟加拉国已得到广泛研究，包括从流行病学到发病机制。在孟加拉国进行的创新疗法临床试验已显示出前景。丙型肝炎病毒是该国慢性肝病的第二大常见病因，仅次于乙型肝炎病毒。然而，孟加拉国的患者已开始从新引入的直接抗病毒药物的本地仿制药中受益。
Al-Mahtab M. 孟加拉国病毒性肝炎的过去、现在和未来。《欧亚肝脏胃肠病学杂志》2016；6(1)：43 - 44。
